Bellati, Filippo <br/><br/>
Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.  [electronic resource] 

 -  Investigational new drugs  Dec 2010 
 - 887-94 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-009-9351-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Ascites--drug therapy<br/>Bevacizumab<br/>Fatal Outcome<br/>Female<br/>Humans<br/>Injections, Intraperitoneal<br/>Interferon-gamma--biosynthesis<br/>Lymphocyte Subsets--immunology<br/>Middle Aged<br/>Ovarian Neoplasms--complications<br/>Pilot Projects<br/>Randomized Controlled Trials as Topic<br/>Recurrence<br/>Remission Induction